Skip to main content
. 2021 Jun 21;43(7):886–891. doi: 10.1017/ice.2021.249

Fig. 4.

Fig. 4.

GUV inactivation of HCoV-229E on intact N95 respirators is subject to differential efficacy based on location of inoculation. (A) Graphical representation of the zones on the N95 respirators that were spotted with microdroplets of HCoV-229E. Zones 1–4 represent (1) nose, (2) right cheek, (3) left cheek, and (4) chin. (B) Plaque assay after UV treatment of HCoV-229E-contaminated respirators, separated by zone in the small or large UV devices. Data are representative of 3 independent experiments with 3 technical replicates per experiment (n = 9). Error bars represent SD. Statistical significance was determined using an unpaired t test.